Mealey's (March 23, 2020, 12:47 PM EDT) -- SAN DIEGO — A California appeals panel on March 20 held that a lower court erred in finding that plaintiffs have demonstrated a probability of prevailing on the merits of their libel, false light and unfair competition claims arising from the publication of an article regarding the safety of a cannabidiol (CBD) product, reversing and remanding with directions to enter an order granting the defendants' motion to strike these three claims under California’s strategic lawsuit against public participation (anti-SLAPP) statute (Medical Marijuana, Inc., et al. v. ProjectCBD.com, et al., No D074755, Calif. App., 4th Dist., Div. 1, 2020 Cal. App. LEXIS 233)....